3C-E: Difference between revisions
Jump to navigation
Jump to search
m Protected "3C-E": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
Line 28: | Line 28: | ||
==Reference== | ==Reference== | ||
{{reflist}} | {{reflist|2}} | ||
== External links == | == External links == |
Latest revision as of 13:48, 4 September 2012
3C-E | |
---|---|
Chemical name | 3,5-Dimethoxy-4-ethoxy-amphetamine or 1-(4-ethoxy-3,5-dimethoxyphenyl)propan-2-amine |
Chemical formula | C13H21NO3 |
Molecular mass | 239.31 g/mol |
Melting point | - |
CAS number | 146849-92-5 |
SMILES | NC(C)CC1=CC(OC)=C(OCC)C(OC)=C1 |
Chemical structure of 3C-E File:3C-E-3d-sticks.png |
3C-E is a psychedelic hallucinogenic drug and entheogen of the phenethylamine class of compounds. 3C-E was probably first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines I Have Known and Loved), Shulgin lists the dosage range as 30 to 60 mg, consumed orally. The duration of action was stated to be 8-12 hours [1]. 3C-E can be considered illegal in the U.S. as a result of the Analogue Act, although it is not itself scheduled; it is also illegal in Australia.
This compound is the three-carbon chain analogue of escaline.